898 TREATMENT WITH TELAPREVIR/PEG-IFN/RBV AFTER 14-DAY TELAPREVIR EXPOSURE IN PHASE I STUDIES: RESULTS FROM THE PHASE IIIB C219 ROLLOVER STUDY
Sarrazin, C., Reesink, H.W., Zeuzem, S., Dierynck, I., Luo, D., Witek, J., Picchio, G., De Meyer, S.Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)60900-9
Date:
April, 2013
File:
PDF, 76 KB
english, 2013